Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
2,489
Views
9
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

Suvimol Niyomnaithama Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand;b Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandView further author information
,
Zheng Quan Tohc Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia;d Department of Pediatrics, The University of Melbourne, Parkville, Victoria, AustraliaView further author information
,
Patimaporn Wongprompitake Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandView further author information
,
Laddawan Jansarikitb Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandView further author information
,
Kanjana Srisutthisamphanf National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science Development Agency (NSTDA), Pathum thani, ThailandView further author information
,
Sompong Sapsutthipasg Department of Medical Sciences, Institute of Biological Products, Bangkok, ThailandView further author information
,
Yuparat Jantraphakornf National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science Development Agency (NSTDA), Pathum thani, ThailandView further author information
,
Natthakarn Mingngamsupg Department of Medical Sciences, Institute of Biological Products, Bangkok, ThailandView further author information
,
Paul V Licciardic Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia;d Department of Pediatrics, The University of Melbourne, Parkville, Victoria, AustraliaView further author information
&
Kulkanya Chokephaibulkita Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand;h Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0140-4600View further author information
ORCID Icon show all
Article: 2091865 | Received 04 Apr 2022, Accepted 13 Jun 2022, Published online: 11 Jul 2022

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Paskorn Sritipsukho, Thana Khawcharoenporn, Boonying Siribumrungwong, Pansachee Damronglerd, Nuntra Suwantarat, Araya Satdhabudha, Chanapai Chaiyakulsil, Phakatip Sinlapamongkolkul, Auchara Tangsathapornpong, Pornumpa Bunjoungmanee, Sira Nanthapisal, Chamnan Tanprasertkul, Naiyana Sritipsukho, Chatchai Mingmalairak, Anucha Apisarnthanarak & Pichaya Tantiyavarong. (2023) Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?. Emerging Microbes & Infections 12:1.
Read now
Chenchit Chayachinda, Kanokwaroon Watananirun, Chayawat Phatihattakorn, Sanitra Anuwutnavin, Suvimol Niyomnaitham, Wanatpreeya Phongsamart, Keswadee Lapphra, Orasri Wittawatmongkol, Supattra Rungmaitree, Laddawan Jansarikit, Kobporn Boonnak, Patimaporn Wongprompitak, Sansnee Senawong, Avishek Upadhya, Zheng Quan Toh, Paul V. Licciardi & Kulkanya Chokephaibulkit. (2023) Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women. Human Vaccines & Immunotherapeutics 19:2.
Read now
Moe H. Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh & Amit Srivastava. (2023) Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines. Human Vaccines & Immunotherapeutics 19:1.
Read now

Articles from other publishers (6)

Wen Kang, Peng Yang, Bianli Dang, Wenjing Zhang, Yi Gang, Wei Wang, Chunyan Ma, Yanyan Zhao, Ying Zhang, Chunqiu Hao, Huiqin Quan, Jing Li, Jiaojiao Cao, Wenzhen Kang & Lei Shang. (2023) Dynamics of disease characteristics and viral RNA decay in patients with asymptomatic and mild infections during the Omicron wave in Shanghai, China: A retrospective cohort study. International Journal of Infectious Diseases 130, pages 60-70.
Crossref
Nicolas Guibert, Kylian Trepat, Bruno Pozzetto, Laurence Josset, Jean-Baptiste Fassier, Omran Allatif, Kahina Saker, Karen Brengel-Pesce, Thierry Walzer, Philippe Vanhems & Sophie Trouillet-Assant. (2023) A third vaccine dose equalises the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Lyon, France, December 2021 to March 2022. Eurosurveillance 28:15.
Crossref
Suvimol Niyomnaitham, Anan Jongkaewwattana, Atibordee Meesing, Nawamin Pinpathomrat, Sira Nanthapisal, Nattiya Hirankarn, Sarawut Siwamogsatham, Suppachok Kirdlarp, Romanee Chaiwarith, Saranath Lawpoolsri, Supranee Phanthanawiboon, Arunee Thitithanyanont, Pokrath Hansasuta, Sansanee Chaiyaroj & Punnee Pitisuttithum. (2023) Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants. International Journal of Infectious Diseases 129, pages 19-31.
Crossref
Tavitiya Sudjaritruk, Oramai Mueangmo, Jutamad Saheng, Poramed Winichakoon, Parichat Salee, Worawan Wongjak, Tanachot Chaito, Jutarat Praparattanapan, Khanuengnit Nuket, Nuttarika Solai, Jiraprapa Wipasa, Kriangkrai Chawansuntati & Romanee Chaiwarith. (2023) Comparison of Immunogenicity and Reactogenicity of Five Primary Series of COVID-19 Vaccine Regimens against Circulating SARS-CoV-2 Variants of Concern among Healthy Thai Populations. Vaccines 11:3, pages 564.
Crossref
Somruedee Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, Zheng Quan Toh, Paul V. Licciardi, Patimaporn Wongprompitak, Thaneeya Duangchinda, Pattarakul Pakchotanon, Warangkana Chantima & Kulkanya Chokephaibulkit. (2022) Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination. Frontiers in Immunology 13.
Crossref
Monica Franzese, Luigi Coppola, Romina Silva, Stefano Angelo Santini, Luigi Cinquanta, Cosimo Ottomano, Marco Salvatore & Mariarosaria Incoronato. (2022) SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance. Frontiers in Immunology 13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.